Showing results (111-120 of 216) with videos related to
Sort By:
Pageof 22
Resuscitation|December 19, 2016
The association of maximum Troponin values post out-of-hospital cardiac arrest with electrocardiographic findings, cardiac reperfusion procedures and survival to discharge: A sub-study of ROC PRIMEDLaurie J Morrison, Sean M Devlin, Michael C Kontos, et al.The Journal of Experimental Medicine|August 3, 2019
CD97 is a critical regulator of acute myeloid leukemia stem cell functionGaëlle H Martin, Nainita Roy, Sohini Chakraborty, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 24, 2019
Romiplostim Treatment of Chemotherapy-Induced ThrombocytopeniaGerald A Soff, Yimei Miao, Gemma Bendheim, et al.Leukemia & Lymphoma|January 13, 2017
Gain of chromosome 1q portends worse prognosis in multiple myeloma despite novel agent-based induction regimens and autologous transplantationGunjan L Shah, Heather Landau, Dory Londono, et al.The Oncologist|October 9, 2015
Prognostic Importance of Pretransplant Functional Capacity After Allogeneic Hematopoietic Cell TransplantationLee W Jones, Sean M Devlin, Molly A Maloy, et al.Plos One|March 23, 2019
Baseline identification of clonal V(D)J sequences for DNA-based minimal residual disease detection in multiple myelomaEven H Rustad, Malin Hultcrantz, Venkata D Yellapantula, et al.Haematologica|October 15, 2020
Pediatric-inspired chemotherapy incorporating pegaspargase is safe and results in high rates of minimal residual disease negativity in adults up to age 60 with Philadelphia chromosome-negative acute lymphoblastic leukemiaMark B Geyer, Ellen K Ritchie, Arati V Rao, et al.Journal of Neurotrauma|February 21, 2014
Addressing the challenges of obtaining functional outcomes in traumatic brain injury research: missing data patterns, timing of follow-up, and three prognostic modelsLeila R Zelnick, Laurie J Morrison, Sean M Devlin, et al.JCI Insight|April 3, 2019
Safety and tolerability of conditioning chemotherapy followed by CD19-targeted CAR T cells for relapsed/refractory CLLMark B Geyer, Isabelle Rivière, Brigitte Sénéchal, et al.Transplantation and Cellular Therapy|October 14, 2020
Letermovir for Prevention of Cytomegalovirus Reactivation in Haploidentical and Mismatched Adult Donor Allogeneic Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease ProphylaxisAndrew Lin, Jessica Flynn, Lauren DeRespiris, et al.Pageof 22